Literature DB >> 10483791

Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane.

I Higuchi1, T Niiyama, Y Uchida, M Inose, M Nakagawa, K Arimura, M Osame.   

Abstract

We previously reported a patient with Becker muscular dystrophy (BMD) who exhibited a benign clinical phenotype and marked expression of utrophin on the muscle cell membrane. The patient developed multiple episodes of thrombosis (middle cerebral and femoral arteries) in the course of the disease. We re-examined the biopsy muscle specimen from the patient immunohistochemically as to the expression of procoagulant or anticoagulant factors. We found a lower expression of thrombomodulin on the muscle cell membrane in the BMD patient compared with other BMD or Duchenne muscular dystrophy (DMD) patients. Although utrophin up-regulation in muscle is thought to prevent the muscle wasting in dystrophin-deficient DMD or BMD, the data obtained in the present study indicate that up-regulated utrophin may have an unexpected influence on the function of the vascular or coagulation system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483791     DOI: 10.1007/s004010051086

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Molecular mechanism of rigid spine with muscular dystrophy type 1 caused by novel mutations of selenoprotein N gene.

Authors:  Yuji Okamoto; Hiroshi Takashima; Itsuro Higuchi; Wataru Matsuyama; Masahito Suehara; Yasushi Nishihira; Akihiro Hashiguchi; Ryuki Hirano; Arlene R Ng; Masanori Nakagawa; Shuji Izumo; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Neurogenetics       Date:  2006-06-15       Impact factor: 2.660

2.  Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.

Authors:  Luis A Cea; Carlos Puebla; Bruno A Cisterna; Rosalba Escamilla; Aníbal A Vargas; Marina Frank; Paloma Martínez-Montero; Carmen Prior; Jesús Molano; Isabel Esteban-Rodríguez; Ignacio Pascual; Pía Gallano; Gustavo Lorenzo; Héctor Pian; Luis C Barrio; Klaus Willecke; Juan C Sáez
Journal:  Cell Mol Life Sci       Date:  2016-01-23       Impact factor: 9.261

3.  A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy.

Authors:  Yusuke Sakiyama; Yuji Okamoto; Itsuro Higuchi; Yukie Inamori; Yoko Sangatsuda; Kumiko Michizono; Osamu Watanabe; Hideyuki Hatakeyama; Yu-ichi Goto; Kimiyoshi Arimura; Hiroshi Takashima
Journal:  Acta Neuropathol       Date:  2011-03-22       Impact factor: 17.088

4.  Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.

Authors:  Emanuele Gallinoro; Andrea Antonio Papa; Anna Rago; Simona Sperlongano; Antonio Cassese; Nadia Della Cioppa; Maria Cristina Giada Magliocca; Giovanni Cimmino; Paolo Golino
Journal:  Acta Myol       Date:  2018-09-01

5.  Pulmonary thromboembolism in a patient with myotonic dystrophy type 1.

Authors:  Joong-Yang Cho; So-Young Seo; Yong-Jin Cho; Keun-Sik Hong; Hee Kyung Park; Ju Hyun Lee; Sung-Soon Lee
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

6.  Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.

Authors:  Yujiro Higuchi; Ryuta Okunushi; Taichi Hara; Akihiro Hashiguchi; Junhui Yuan; Akiko Yoshimura; Kei Murayama; Akira Ohtake; Masahiro Ando; Yu Hiramatsu; Satoshi Ishihara; Hajime Tanabe; Yuji Okamoto; Eiji Matsuura; Takehiro Ueda; Tatsushi Toda; Sumimasa Yamashita; Kenichiro Yamada; Takashi Koide; Hiroaki Yaguchi; Jun Mitsui; Hiroyuki Ishiura; Jun Yoshimura; Koichiro Doi; Shinichi Morishita; Ken Sato; Masanori Nakagawa; Masamitsu Yamaguchi; Shoji Tsuji; Hiroshi Takashima
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.